Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06229275 · ClinicalTrials.gov registry record · NA
Comparing Effectiveness of Physician-assisted Versus Self-assisted Pap Smear Collection
A NA study of Cervical Cancer Screening, sponsored by Morehouse School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06229275: Recruiting NA study of Cervical Cancer Screening, sponsored by Morehouse School of Medicine.
NCT06229275 is a NA study of Cervical Cancer Screening that is actively recruiting participants, run by Morehouse School of Medicine. The registered enrollment target is 200 participants, below the 298-participant average among 6 other Cervical Cancer Screening trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06229275, a NA study of Cervical Cancer Screening, is actively recruiting participants, sponsored by Morehouse School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This purpose of this research study is to determine the effectiveness of the Personal Pap Smear Device™ to collect adequate cervical cell samples for cytology examination when compared with the Rover Cervex-Brush (Cervix-Examination Brush).
Primary Outcome
Data of Adequate versus Inadequate will be reported to include a positive percent agreement (PPA) defined as PPA= A/(A+C) and the negative percent agreement (NPA) defined as NPA = D/(B+D) along with their 95% confidence bounds using the Clopper-Pearson method.
Conditions Studied
Interventions
- DEVICE Pap smear collection using the Personal Pap Smear (PPS) Device
- DEVICE Active Comparator: Pap smear collection using the Rovers Cervex-Brush
Study Locations (1)
Georgia
- Morehouse School of Medicine - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-07-25 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
What NCT06229275 shows while recruiting
NCT06229275 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 298-participant average among 6 other Cervical Cancer Screening trials with a reported enrollment target (33% lower).
The record links to 1 condition, with Cervical Cancer Screening appearing as the primary indexed condition, and to 2 interventions - of which Pap smear collection using the Personal Pap Smear (PPS) Device is the first listed.
NCT06229275 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06229275 about?
NCT06229275 is a clinical study titled "Comparing Effectiveness of Physician-assisted Versus Self-assisted Pap Smear Collection". This purpose of this research study is to determine the effectiveness of the Personal Pap Smear Device™ to collect adequate cervical cell samples for cytology examination when compared with the Rover Cervex-Brush (Cervix-Examination Brush).
What is the current status of trial NCT06229275?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-07-25. Estimated completion is 2026-03-30.
What conditions does trial NCT06229275 study?
This clinical trial studies the following conditions: Cervical Cancer Screening.
What interventions are being tested in trial NCT06229275?
The interventions under investigation include: Pap smear collection using the Personal Pap Smear (PPS) Device (DEVICE), Active Comparator: Pap smear collection using the Rovers Cervex-Brush (DEVICE).
Who is sponsoring clinical trial NCT06229275?
This trial is sponsored by Morehouse School of Medicine, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06229275 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
RECRUITING · NA
-
St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic
RECRUITING · NA
-
Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer
ACTIVE NOT RECRUITING · NA
-
Multilevel Intervention Based on Colorectal Cancer (CRC) and Cervical Cancer Self-screening in Rural, Segregated Areas
COMPLETED · NA
-
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women
COMPLETED · NA
-
Emergency Room HPV Self-Sampling Study (ACT NOW)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI